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Here we show the molecular basis for the inhibition of peptidoglycan (PGN)-induced TLR2 signaling
by a major green tea polyphenol epigallocatechin-3-gallate (EGCG). Recently, we identiﬁed the 67-
kDa laminin receptor (67LR) as the cell-surface EGCG receptor. Anti-67LR antibody treatment or
silencing of 67LR resulted in abrogation of the inhibitory action of EGCG on PGN-induced production
of pro-inﬂammatory mediators and activation of mitogen-activated protein kinases. Silencing of
Toll-interacting protein (Tollip), a negative regulator of TLR signaling impaired the TLR2 signaling
inhibitory activity of EGCG, suggesting that TLR2 response could be inhibited by EGCG via 67LR
and Tollip.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Green tea (Camellia sinensis L.) is one of the most popular bever-Toll-like receptors (TLRs) are a family of membrane proteins
that trigger innate immune responses and are pathogen recogni-
tion proteins that have important roles in detecting microbes [1].
Among several kinds of TLRs, TLR2 is preferentially involved in
the inﬂammatory response to lipoteichoic acid, lipopeptides, and
glycans from a variety of microbes [1]. Peptidoglycan (PGN), a ma-
jor component of the cell wall of gram-positive bacteria, is one of
the most powerful activators of TLR2 signaling [2,3]. PGN induces
most of the clinical manifestations of bacterial infections, including
inﬂammation, fever and septic shock [4]. Most of these effects are
due to the activation of macrophages and production of pro-
inﬂammatory cytokines, such as tumor necrosis factor-a (TNF-a)
and interleukin (IL)-6 [5,6].chemical Societies. Published by E
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chibana).ages in the world, and it has been reported that daily consumption
of green tea is associated with many important health beneﬁts,
such as a reduced risk of atherosclerosis and cancer [7,8]. The
beneﬁcial properties of green tea are attributable to its abundant
polyphenolic compounds, known as catechins. The green tea
polyphenols include catechin, ()-epicatechin (EC), ()-epigalloca-
techin (EGC), ()-epicatechin-3-gallate (ECG), and ()-epigalloca-
techin-3-gallate (EGCG). Of these, EGCG is a predominant
catechin and has a variety of biological and pharmacological prop-
erties including cancer-preventive, anti-allergic, anti-oxidative
stress and anti-inﬂammatory activities [8–11].
Activation of TLR2 in response to PGN induces activation of the
mitogen-activated protein kinase (MAPK) pathway, nuclear factor-
jB (NF-jB) and induction of pro-inﬂammatory cytokines [12,13].
Recently, it has been reported that EGCG inhibited MAPK phos-
phorylation and subsequently suppressed both IjBa-dependent
and -independent signal transduction pathways for the activation
of NF-jB, leading to the expression of cytokines and chemokines
induced by caries-related bacteria and TLR2 ligand [14]. Although
some mechanisms for the anti-inﬂammatory activities of EGCG
have been proposed, the molecular mechanism for this inhibitory
action of EGCG on TLR2 signaling is has not yet been established.
The 67-kDa laminin receptor (67LR) is a non-integrin
cell-surface receptor for laminin with high afﬁnity [15]. Its role
as a laminin receptor makes it an important molecule in celllsevier B.V. All rights reserved.
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cells [16]. An increase in the expression of 67LR as compared with
the corresponding normal tissue has been found in a variety of
tumor cells [17,18]. Furthermore, the protein interacts speciﬁcally
with the major Dengue virus serotypes [19]. Recently, we identi-
ﬁed 67LR as a cell-surface EGCG receptor that mediates the
anti-cancer action of physiologically achievable concentrations
(0.1–1 lM) of EGCG [20]. Others showed that RNAi-mediated
silencing of 67LR results in abrogation of EGCG-induced apoptosis
in multiple myeloma cells [21]. Furthermore, this receptor has also
been shown to be responsible for the inhibitory action of EGCG on
degranulation in basophils [22,23]. In macrophages, EGCG inhibits
LPS-induced TLR4 signaling through 67LR [24]. However, it is not
clear whether EGCG action through 67LR involves the negative reg-
ulatory effect of EGCG on TLR2 ligand PGN-induced inﬂammatory
responses. In this study, we tried to illuminate the molecular basis
for the downregulation of TLR2 signal transduction by EGCG. Here
we show that 67LR and Tollip are indispensable for mediating anti-
inﬂammatory action of EGCG on TLR2 signaling. Our ﬁnding pro-
vides a new insight into the understanding of negative regulatory
mechanisms for the TLR2 signaling pathway.Fig. 1. Anti-inﬂammatory action of EGCG is mediated through the 67LR. Thiogly-
collate-elicited murine peritoneal macrophages were incubated with either anti-
67LR antibody or control antibody for 1 h, and the cells were pretreated with EGCG
(1 lM) for 1 h before exposure to PGN for 24 h. The amount of TNF-a (A) and IL-6
(B) in culture medium was measured by ELISA. All data were expressed as the
means ± S.D. (n = 3). Statistical signiﬁcance was analyzed by Student’s t-test. The
value of ⁄⁄⁄P < 0.001 was considered to be statistically signiﬁcant. The value of n.s.
was deﬁned as no signiﬁcant effect.2. Materials and methods
2.1. Reagents
EGCG, PGN, anti-b-actin polyclonal antibody, and horseradish
peroxidase (HRP)-conjugated anti-rabbit antibody were purchased
from Sigma (St. Louis, MO). Anti-67LR monoclonal antibody
(MLuC5) was purchased from NeoMarkers (Fremont, CA). Anti-
TLR2 polyclonal antibody, anti-MyD88 polyclonal antibody, an-
ti-CD14 polyclonal antibody, anti-Tollip monoclonal antibody,
anti-phosphorylated ERK1/2 monoclonal antibody, anti-ERK1/2
polyclonal antibody, anti-phosphorylated JNK monoclonal anti-
body, anti-JNK polyclonal antibody, anti-phosphorylated p38
monoclonal antibody, anti-p38 polyclonal antibody and horserad-
ish HRP-conjugated anti-goat donkey IgG antibody were obtained
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and HRP-con-
jugated anti-mouse IgG antibody, HRP-conjugated streptavidin and
anti-mouse IgM antibody were obtained from Zymed Laboratories
(San Francisco, CA). HRP-conjugated anti-rabbit antibody was pur-
chased from ICN Pharmaceuticals (Aurora, OH). An anti-mouse
TNF-a antibody was obtained from Endogen (Woburn, MA). Biotin-
ylated anti-mouse TNF-a antibody was obtained from Biosource
(Camarillo, CA). IL-6 ELISA kit was obtained from eBioscience
(San Diego, CA).
2.2. Isolation of peritoneal macrophages
Thioglycollate-elicited peritoneal macrophages were obtained
from speciﬁc pathogen-free male BALB/c mice at 6–8 weeks of
age by injection of 1 ml of sterile 3% thioglycollate solution (Difco,
Detroit, MI) for 4 days before lavage with 10 ml of phosphate buf-
fered saline. The peritoneal macrophages were washed once with
RPMI-1640 (without phenol red) supplemented with 10% endo-
toxin-free heat-inactivated fetal bovine serum (Intergen, Purchase,
NY), 100 U/ml penicillin, and 100 U/ml streptomycin. The cells
were resuspended in RPMI-1640 at a density of 2  106 cells/ml.
The cells were plated and incubated for 4 h at 37 C in a humidiﬁed
incubator containing 5% CO2 to allow macrophage adherence.
2.3. Cell culture
RAW264.7 cells were cultured in DMEM supplemented with
antibiotics (100 U/ml penicillin and 100 U/ml streptomycin), and10% (v/v) fetal bovine serum (Intergen, Purchase, NY). The cells
were maintained at 37 C in a humidiﬁed incubator containing
5% CO2. In all experiments, cells were allowed to acclimate for
24 h before any treatments.
2.4. Anti-67LR antibody treatment
Thioglycollate-elicited peritoneal macrophages were seeded on
the plates and incubated at 37 C in 5% CO2 for 24 h before any
treatments. The cells were incubated with either anti-67LR anti-
body (20 lg/ml) or control mouse IgM (20 lg/ml) at 37 C in 5%
CO2 for 1 h before the addition of EGCG or LPS.
2.5. Construction of 67LR-suppressed cells
Target sequences for short hairpin RNA (shRNA) for 67LR and
nonspeciﬁc control are as follows: shRNA for 67LR, 5-GGAG-
GAATTTCAGGGTGAA-3; shRNA for nonspeciﬁc control, 5-
GCATATGTGCGTACCTAGCAT-3. The annealed shRNA inserts were
cloned into the psiRNA-hH1neo shRNA expression vector (for
67LR shRNA) (InvivoGen, San Diego) according to the manufac-
turer’s protocol.
2.6. Construction of Tollip-suppressed cells
Tollip shRNA expression vector was purchased from Santa Cruz
Biotechnology. shRNA plasmids consist of a pool of three to ﬁve
lentiviral vector plasmids each encoding target-speciﬁc 19–25 nt
(plus hairpin) shRNAs.
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The amount of TNF-a and IL-6 in culture mediumwas measured
by sandwich enzyme-linked immunosorbent assay (ELISA). Anti-
body solution diluted at 500 times by PBS was added to a 96-well
plate. After blocking the plate with 1% BSA-PBS, each well was trea-
ted with culture supernatant. The wells were then treated with
biotinylated anti-mouse TNF-a or IL-6 antibodies. HRP-conjugated
streptavidin solution was added to each well. Then, 0.6 mg/ml of
2,20-azinobis (ethylbenzothazoline-6-sulfonic acid diammonium
salt) dissolved in 0.03% H2O2–0.05 M citrate buffer was added to
the well, and the absorbance at 405 nm was measured.
2.8. Measurement of nitric oxide (NO)
The concentration of NO in culture supernatant was determined
as nitrite, by the Griess reagent (1% sulfanilamide/0.1% naphtyleth-
yle-nediamine dihydrochloride in 2.5% H3PO4) (Sigma–Aldrich).Fig. 2. 67LR is indispensable for anti-inﬂammatory action of EGCG in RAW264.7 cells
measured by immunoblot analysis using 67LR antibody. (B) Amounts of TLR2 and CD
immunoblot analysis using each speciﬁc antibody. In both A and B, the lower panel displ
The band intensities quantiﬁed using NIH Image J software. (C) Cells were treated with E
assay. RAW264.7 cells were incubated with EGCG (1 lM) for 1 h and then treated with P
by ELISA. NO level (F) in the culture medium was measured by the Griess assay. All data
Student’s t-test. The value of ⁄⁄P < 0.01 was considered to be statistically signiﬁcant. TheCells were seeded into a 6-well plate at 3  105 cells/well in 3 ml
of complete medium per well and incubated for 24 h at 37 C.
The cells were pretreated with 1 lM EGCG for 1 h and stimulated
with LPS (50 ng/ml) for 24 h. Supernatant of cell culture medium
was collected and assayed for NO production using the Griess re-
agent. The concentration of nitrite was converted into sodium ni-
trite concentration as a standard.
2.9. Immunoblot analysis
Cells were lysed in 100 ll of lysis buffer containing 50 mM Tris–
HCl (pH 7.5), 150 mM NaCl, 1% Triton-X 100, 1 mM EDTA, 50 mM
NaF, 30 mM Na4P2O7, 1 mM phenylmethanesulfonyl ﬂuoride,
2 lg/ml aprotinin, and 1 mM pervanadate. Whole cell lysate sam-
ples were separated by 8% sodium dodecyl sulfate–polyacrylamide
gel electrophoresis and electrotransferred to nitrocellulose mem-
branes. The nitrocellulose membranes were incubated with pri-
mary antibodies, followed by incubation with HRP-conjugated. (A) Expression of 67LR in the cells transfected with the 67LR-shRNA vector was
14 expressions in the 67LR-downregulated and control cells were measured by
ays protein levels from the same ﬁlter blotted again with the anti-b-actin antibody.
GCG (0, 1, 5, 10 and 20 lM) for 24 h, and the cell viability was assessed by a WST-1
GN for 24 h. The amount of TNF-a (D) and IL-6 (E) in culture medium was measured
were expressed as the means ± S.D. (n = 3). Statistical signiﬁcance was analyzed by
value of n.s. was deﬁned as no signiﬁcant effect.
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alized by using enhanced chemiluminescence advance kit (GE
Healthcare, Little Chalfont, UK).
2.10. Statistical analysis
All datawere expressed as themean ± S.D. Statistical signiﬁcance
was analyzedby Student’s t-test. Each value of ⁄P < 0.05, ⁄⁄P < 0.01 or
⁄⁄⁄P < 0.001 was considered to be statistically signiﬁcant.
3. Results
3.1. EGCG suppresses PGN-induced production of inﬂammatory
mediators in peritoneal macrophages through 67LR
To examine the effect of EGCG at a physiological concentration
(1 lM) mediated through 67LR on the production of inﬂammatory
mediators from murine peritoneal macrophages, the cells were
treated with either isotype-matched control antibody or anti-
67LR antibody which has been shown to be able to block the bind-
ing of EGCG to the cell surface 67LR [20]. Each antibody-treated
cells were pretreated for 1 h with 1 lM EGCG prior to exposure
to PGN. As shown in Fig. 1, production of TNF-a and IL-6 in culture
supernatant from murine peritoneal macrophages were increased
upon treatment with PGN, and the PGN-induced production of
these inﬂammatory mediators was inhibited by 1 lM EGCG treat-
ment. However, in anti-67LR antibody-treated cells, the inhibitory
effects of EGCG were signiﬁcantly lower than that observed in con-Fig. 3. EGCG inhibits PGN-induced activation of MAPK signal pathway though 67LR. RAW
then stimulated with PGN for 30 min. Cells lysates were subjected to SDS–PAGE and imm
ERK1/2), ERK1/2, phospho-JNK (p-JNK), JNK, phospho-p38 (p-p38) and p38. Band intensit
an internal control, and relative band intensity was expressed as a percentage comparetrol antibody-treated cells (Fig. 1). These results indicate that the
ability of EGCG to reduce the production of inﬂammatory media-
tors is mediated through its binding to the 67LR.
3.2. Downregulation of 67LR in RAW264.7 cells ameliorated the
suppressive effect of EGCG on PGN-induced inﬂammatory action
To explore whether the effects of EGCG on cellular responses to
PGN stimulation could be mediated through 67LR, RAW264.7 mac-
rophages were stably transfected with shRNA expression vector to
reduce 67LR expression. Total cellular 67LR expression was
lowered in RAW264.7 cells transfected with shRNA for 67LR
(Fig. 2A). Generally, TLR2 has been shown to have a crucial role
in PGN-induced inﬂammatory response, and CD14 is also required
as a co-receptor for TLR2 to recognize PGN [25]. We evaluated the
amounts of TLR2 and CD14 expressions in 67LR-downregulated
cells and control cells. Immunoblot analysis indicated that the
expression of TLR2 and CD14 in 67LR-downregulated cells was
not altered as compared with the control cells (Fig. 2B). This result
suggested that the silencing of 67LR did not affect the expression of
TLR2 and CD14, and that the binding of PGN to TLR2 may be equal
in the both 67LR-downregulated cells and control cells. In in vitro
assays, we also measured the cytotoxic effect of EGCG on both
67LR-downregulated cells and control cells. The cells were treated
with 1, 5, 10 or 20 lM EGCG for 24 h to assess the cell viability. As
shown in Fig. 2C, EGCG up to 20 lM did not display any cellular
toxicity against RAW264.7 cells. Thus, the effects of EGCG were
not attributable to cytotoxic effects.264.7 cells were pretreated with the indicated concentrations of EGCG for 1 h, and
unoblot analysis was performed using each speciﬁc antibody to phospho-ERK1/2 (p-
ies were quantiﬁed using NIH Image J software. The total MAPK levels were used as
d with the value of untreated control.
Fig. 4. Effect of EGCG thought 67LR on TLR2 protein expression. (A) RAW264.7 cells
were treated with 1 lM EGCG for 1 h. (B) Control-shRNA cells without PGN
stimulation were treated with 1 lM EGCG for 24 h. (C) Thioglycollate-elicited
murine peritoneal macrophages were incubated with either anti-67LR antibody or
control antibody for 1 h and then treated with 1 lM EGCG for 1 h. Cell lysates were
subjected to SDS–PAGE and total TLR2 protein expression was determined by
immunoblotting with speciﬁc anti-TLR2 antibody. Band intensities were quantiﬁed
using NIH Image J software. Relative band intensity was expressed as a percentage
compared with the value of untreated control.
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duced readily in response to PGN. To test whether the 67LR silenc-
ing affects PGN-induced inﬂammatory responses, we stimulated
67LR-downregulated RAW264.7 cells with PGN. We found that
downregulation of 67LR did not affect PGN-induced production
of these mediators (Fig. 2D–F). Both 67LR-downregulated and con-
trol cells were pretreated with 1 lM EGCG for 1 h prior to stimula-
tion with 10 lg/ml PGN for 24 h. Production of TNF-a, IL-6 and NO
were signiﬁcantly inhibited upon treatment with 1 lM EGCG. Fur-
thermore, the addition of catalase (200 U/ml), this concentration
has been reported to be effective to diminish the H2O2 generation
induced by catechins [26–28], could not affect the EGCG-induced
inhibition of inﬂammatory cytokine release from RAW264.7 cells
(data not shown). In addition, EGCG at low concentration (1 lM)
used in this study has been shown to do not cause appreciable gen-
eration of H2O2 in cell culture media [26–28]. These ﬁndings sug-
gest that the inhibitory action of EGCG for the inﬂammatory
mediators release is caused by the H2O2-independent effect.
However, this inhibitory effect was not observed in 67LR-downreg-
ulated cells (Fig. 2D–F). These results indicate that 67LR mediates
the suppressive effect of a physiologically relevant EGCG on the
production of PGN-induced inﬂammatory mediators in
macrophages.
3.3. Effect of 67LR-downregulation on EGCG-induced inactivation of
MAPK signal pathway
TLR2 signaling activated by the PGN leads to the activation of
MAPK pathway including ERK1/2, p38 and JNK [2,3]. In addition,
expressions of inﬂammatory cytokines such as TNF-a and IL-6 are
increased by activation ofMAPKs [29].We examinedwhether EGCG
suppresses PGN-induced MAPK activation through 67LR. The phos-
phorylation ofMAPKs including ERK1/2, p38 and JNKwasmeasured
by immunoblot analysis using speciﬁc antibodies. As shown in
Fig. 3, PGN-induced phosphorylation of ERK1/2, p38 and JNK were
inhibited by the treatment of EGCG in dose-dependent manner.
However, in 67LR-downregulated cells, the inhibitory effect of
EGCG on PGN-induced upregulation of phosphorylation was lower
than that of the inhibitory effect of EGCG in control cells. These re-
sults indicate that EGCG inhibits MAPKs pathway through 67LR.
3.4. Effect of EGCG on TLR2 protein expression
To investigate whether EGCG suppresses the expression of TLR2
protein, both control and 67LR-downregulated cells were treated
with 1 lM EGCG for 1 h. The total protein level of TLR2 was mea-
sured by immunoblot analysis. In both 67LR-downregulated cells
and control cells, total protein level of TLR2 was not affected under
a 1 h EGCG treatment (Fig. 4A). Furthermore, the inhibitory effect
of EGCG in the expression of TLR2 protein was not observed after
a 24 h treatment (Fig. 4B). We also examined the effect of EGCG
on TLR2 expression in primary macrophages. Murine peritoneal
macrophages were incubated with either anti-67LR antibody or
control antibody for 1 h, then treated with EGCG (1 lM) for 1 h.
EGCG did not inhibit the expression of TLR2 protein in primary
macrophages (Fig. 4C). These results suggest that inhibitory effect
of EGCG on TLR2 signaling is not due to the prevention of interac-
tion of PGN with TLR2.
3.5. Tollip mediates the TLR2 signaling inhibitory action of EGCG
Overexpression of Tollip causes suppression of TLR2-mediated
NF-jB activation, indicating that Tollip negatively regulates TLR
signaling [30]. In addition, our previous study showed that EGCG
induced a rapid upregulation of Tollip through 67LR [23]. There-
fore, to establish whether Tollip is indeed involved in the suppres-sive effect of EGCG on PGN-induced inﬂammatory responses, we
used stable RNAi to silence Tollip expression in RAW264.7 cells.
Immunoblot analysis indicated that stable RNAi for Tollip speciﬁ-
cally silenced Tollip protein expression without affecting the
expression of 67LR (Fig. 5A). In addition, we found that the inhib-
itory action of EGCG on the production of TNF-a and IL-6 was pre-
vented by Tollip silencing (Fig. 5B and C). Together, these results
demonstrate that Tollip is a critical mediator responsible for the
anti-inﬂammatory action of EGCG on TLR2 signaling.
4. Discussion
Cell-surface interactions are one of the most important events
for the initiation of biological responses to extracellular stimuli.
In this paper, we demonstrate that EGCG action through the cell-
surface receptor 67LR can negatively regulate TLR2 signaling.
We have reported for the ﬁrst time that the inhibitory effect of
EGCG on tumor cell proliferation is exerted through its binding to
the 67LR as a cell-surface receptor [20]. We also demonstrated that
EGCG inhibits cell growth by reducing the myosin regulatory light
chain phosphorylation mediated through 67LR [21]. Moreover,
EGCG suppresses the expression of the high-afﬁnity IgE receptor
FceRI and histamine release through its binding to 67LR [22,31].
Fig. 5. Tollip mediates the TLR2 signaling inhibitory action of EGCG. (A) RAW264.7 cells were transfected with the Tollip-shRNA vector. Protein levels of Tollip were detected
by immunoblotting. (B) Cells were incubated with 1 lM EGCG for 1 h prior to a 24-h treatment with 10 lg/ml PGN. The amount of TNF-a and NO in culture medium were
measured by ELISA or the Griess assay, respectively. Statistical signiﬁcance was analyzed by Student’s t-test. The value of ⁄⁄⁄P < 0.001 was considered to be statistically
signiﬁcant. The value of n.s. was deﬁned as no signiﬁcant effect.
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that mediates the anti-inﬂammatory action of EGCG in TLR4 li-
gand-stimulated macrophages [23]. Nonetheless, the relationship
between 67LR and the inhibitory action of EGCG on TLR2-mediaing
inﬂammation has not yet been established. Here we showed that
EGCG signiﬁcantly inhibited the expression of inﬂammatory medi-
ators such as TNF-a, IL-6 and NO by blocking MAPK pathway acti-
vation through 67LR in TLR2 ligand PGN-stimulated macrophages.
These results demonstrate that 67LR has a pivotal role as a cell-sur-
face receptor that mediates the inhibitory action of EGCG for PGN-
triggered signaling in macrophages.
A previous report showed that PGN-induced inﬂammatory ac-
tion is mediated through TLR2-dependent multiple signaling mol-
ecules including myeloid differentiation protein (MyD88), IL-1
receptor-associated kinase (IRAK), tumor necrosis factor receptor-
associated factor 6 (TRAF6), NF-jB-inducing kinase, and the IKK
signaling pathway [5,12]. Recently, it has been reported that EGCG
suppress inﬂammatory reactions via MAPK pathways in TLR2 li-
gand-stimulated dental pulp cells [14]. However, the direct targets
of EGCG to exert anti-inﬂammatory effect on TLR2 signaling have
not been fully identiﬁed. Here we showed that 67LR play a pivotalrole in mediating the anti-inﬂammatory action of EGCG on TLR2
signaling.
Recently we have reported that EGCG suppressed TLR4 expres-
sion through the 67LR [24]. However, EGCG did not inhibit the
expression of TLR2 protein although the activation of MAPKs in
macrophages stimulated with PGN was suppressed by EGCG
(Fig. 4). Our results suggest that EGCG did not directly affect the
interaction of PGN and TLR2. Therefore, we investigated another
inhibitory target responsible for the anti-inﬂammatory action of
EGCG.
The negative regulators of TLRs have become a favorite topic in
the innate immune system. Several studies have reported that TLR-
mediated overactivation of the host immune response is regulated
by several intracellular negative regulators of TLRs including sup-
pressor of cytokine signaling 1, Tollip and IRAK M [32]. Among
the negative regulators of TLRs, Tollip binds the activated IL-1RI
complex, as well as TLR2 and TLR4 complexes [33]. Overexpression
of Tollip impairs IL-1RI-, TLR2-, and TLR4-triggered NF-jB and JNK
signaling pathways [34]. Moreover, our previous study has shown
that Tollip is indispensable for mediating anti-inﬂammatory action
of EGCG on TLR4 signaling, and its protein expression level is
820 E.-H. Byun et al. / FEBS Letters 585 (2011) 814–820upregulated by EGCG through 67LR [23]. Here, we showed that
inhibitory action of EGCG on the inﬂammatory action induced by
PGN is mediated through Tollip. Our ﬁndings demonstrate that Tol-
lip is a critical mediator responsible for anti-TLR2 signaling action
of EGCG, and provide a new insight into the understanding of neg-
ative regulatory mechanisms for TLR2 signaling pathway.
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